5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Por um escritor misterioso
Descrição
Niemann–Pick is a rare autosomal recessive inherited disease that is characterized by excessive accumulation of cholesterol and lipids in cells, leading to apoptosis and neural degeneration. The disease affects numerous body parts such as the brain, nerves, liver, spleen, bone marrow and lungs. Those suffering from the disease suffer from lack of coordination, dystonia; sleep disturbances, difficult in eating and swallowing and frequent bouts of pneumonia.
TRIALS: A Fight for Children with Niemann-Pick Type C, a Fatal Genetic Disease
Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier: Molecular Therapy
A rare disease patient/caregiver perspective on fair pricing and access to gene-based therapies
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption - ScienceDirect
Jennifer Mitchell - Rare Disease Advocate - Life 4 Liam and Friends Foundation
What You See and What You Don't: Diagnosing Niemann Pick, Type C - Complex Child
Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics
Rea of Hope
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards
de
por adulto (o preço varia de acordo com o tamanho do grupo)
